Tibsovo 250 mg, comprimés pelliculés

7680690770013 CH-69077 Tabletten
Tibsovo 250 mg, comprimés pelliculés
Tibsovo 250 mg, comprimés pelliculés
Tibsovo 250 mg, comprimés pelliculés
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
24/05/2025
Summary of Product Characteristics
Français
24/05/2025
Summary of Product Characteristics
Italien
24/05/2025
Patient information leaflet
Allemand
11/07/2024
Patient information leaflet
Français
11/07/2024
Patient information leaflet
Italien
11/07/2024

Detailed composition

Substance Quantity Type Category
ivosidenibum
250.0 MG Substance Wirkstoff (Principe actif)
hypromellosi acetas succinas
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
lactosum monohydricum
10.0 MG Substance HBESI
triacetinum
- Substance HNIDK
E 132
- Substance FIMDK
natrium
- Substance HBESI

Authorization holder

Servier (Suisse) SA

1202 Genève

Authorization information

Swissmedic authorization number
69077
Drug name
Tibsovo, comprimés pelliculés
Galenic form
FILM
ATC Code
L01XM02
Authorization status
Z
Dispensing category
A
First authorization
13/06/2024
Authorization expiration date
12/06/2029
IT Number
07.16.1.
Domain
Human medicine

Package details

Description (FR)
TIBSOVO cpr pell 250 mg bte 60 pce
Description (DE)
TIBSOVO Filmtabl 250 mg Ds 60 Stk
Market launch
13/06/2024
Narcotic (BTM)
No
Buy us a coffee Explore the data